Did you know I used to avoid buying pink things during October? Because I was superstitious and scared? I thought then that I was just a hypochondriac, but now I think I was psychic.
Did you know that breast cancer is the most-researched and best funded of all the cancers? Your purchases of Yoplait (with the pink tops) and awareness mints (with the pink ribbon on the tin) and maybe even your pink Kitchen Aid mixer are helping women like me.
The latest discovery is extremely exciting, and my doctor is communicating with The Powers That Be in San Antonio to get me on board with their clinical trial next year: a breast cancer vaccine.
Even though I already have breast cancer, this vaccine will hopefully be able to prevent a recurrence, especially for women like me who are HER-2 positive. So please, when you have a chance to buy those products that help fund breast cancer research, go for the pink!
NeuVax™ (E75)
NeuVax is a peptide-based immunotherapy that recruits the immune system to fight cancer and activates "Killer T-cells" to target tumors. NeuVax specifically targets cancer while leaving normal, healthy tissues unharmed. The key to NeuVax is a small peptide called E75 that is derived from HER2/neu, a protein expressed by tumors.
Unlike existing monoclonal antibody therapy which requires frequent, ongoing, intravenous (I.V.) infusion, NeuVax can produce continuing activation of the immune system and therapeutic levels of Killer T-cells with a once monthly intradermal (under the skin) dosing schedule that is less expensive and more convenient for both the patient and physician.
NeuVax is currently undergoing clinical testing for the adjuvant (after-surgery) treatment of early-stage HER2/neu-expressing breast and prostate cancer. NeuVax may also be developed to treat other types of solid tumors.
No comments:
Post a Comment